|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Post-Cardiac Surgery Follow-up Clinic (Drs. Shapira, Isakov, and Heller), Internal Medicine H (Dr. Topilsky), and Internal Medicine T (Dr. Pines), the Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
| Abstract |
|---|
|
|
|---|
Objective: To determine the clinical outcome and the long-term results of a second CABG.
Setting: An 1100-bed urban university-affiliated hospital.
Design: Retrieval of data on selected parameters from medical records before surgery and prospective follow-up afterwards.
Patients and methods: We studied the outcomes of 498 consecutive patients who underwent CABG reoperation in our institution from January 1978 to December 1989 and who were followed postoperatively. Their perioperative mortality, morbidity, and long-term follow-up results were re-evaluated. The end points of the study were December 1997, 15 years of follow-up, or the patient's death.
Results: The perioperative mortality rate was 3%. The cumulative survival rates were 90.1%, 74%, and 63.4% at the 5-year, 10-year, and 15-year follow-ups, respectively. The cardiac event-free survival rates were 91.5%, 83.4%, and 67.8% at the 5-year, 10-year, and 15-year follow-ups, respectively. The risk factors adversely affecting long-term survival were advanced age, hypertension, and a low left ventricular ejection fraction (LVEF).
Conclusions: The long-term results of cumulative survival and cardiac event-free survival in patients who underwent CABG reoperation are good. Although this reoperation is safe overall, advanced age, hypertension, and a decreased LVEF significantly increase the surgical risk.
Key Words: cardiac-event free coronary artery bypass grafting long-term follow-up reoperation survival
| Introduction |
|---|
|
|
|---|
Although the surgical results of the CABG reoperation, and the short-term and medium-term survival rates for patients who have undergone this reoperation have been well documented,3 4 5 6 7 8 9 10 11 12 13 14 15 data on the long-term follow-up are incomplete.2 16 17 18 19 20 In this paper, we defined the risk factors associated with CABG reoperation, and we prospectively assessed the long-term prognosis.
| Patients and Methods |
|---|
|
|
|---|
6 years after the primary
procedure (Table 2
). The main indications for CABG reoperation, as obtained from the
diagnostic catheterization reports, are listed in Table 3
. The average number of anastomoses per patient was 3.5 (range, 2 to 5).
Seventy-eight of the patients (20%) had percutaneous transluminal
coronary angioplasty (PTCA) before the CABG reoperation. Seventy-six
patients (15%) had urgent surgery; an intra-aortic balloon pump had
been used preoperatively in 12 of them. CABG reoperation was elective
in 422 patients. Several technical surgical features should be
mentioned: the myocardium was protected by using anterograde
crystalloid cold cardioplegia; the arterial grafts that were used were
pediculated mammary arteries; open or nondiseased grafts were usually
not replaced, and open grafts were not usually ligated after
replacement; the proximal anastomoses were constructed following
removal of the aortic clamp with the help of a side-biting aortic
clamp; and the left ventricle was usually vented.
|
|
|
Statistical Analysis
Univariate analysis was employed to determine predictors of
operative mortality. The variables included the following: age
70
years; gender; preoperative angiographically determined left
ventricular ejection fraction (LVEF) [> 55%, 31 to 54%, or
< 30%]; resting arterial hypertension (> 150/90 mm Hg); renal
insufficiency (serum creatinine > 2.1 mg/dL); diabetes mellitus;
hyperlipidemia (total cholesterol > 240 mg/dL or low-density
lipoprotein cholesterol > 140 mg/dL); and the time interval from the
first CABG to the second CABG (< 1 year, 1 to 5 years, 6 to 10
years, or > 10 years). Actuarial analysis (using the
Kaplan-Meier test) was employed to assess mortality and cardiac events.
| Results |
|---|
|
|
|---|
1 year after the first one, the
perioperative mortality was significantly higher than it was for the
others (3/30 vs 12/468; p < 0.05). Other independent risk factors
that correlated with perioperative mortality (p < 0.05) were LVEF
< 30% (3 fatalities in 27 cases), diabetes mellitus (7 fatalities in
129 cases), and age > 70 years (9 fatalities in 169
cases). In the 238 patients who had CABG reoperation because of
graft failure, patients with grafts that we found to be both patent and
stenotic bore a greater risk of having to undergo reoperation than
patients with occluded grafts did. Graft failure occurred in 24
patients. Eleven of these patients died, 9 had an MI, and 4 had a
neurologic event in the perioperative period. Sixteen of these patients
had grafts that were patent but stenotic; however, the
difference in mortality and perioperative morbidity between these
patients and those with occluded grafts was not significant. The
complications of surgery are listed in Table 4 .
|
|
|
|
| Discussion |
|---|
|
|
|---|
CABG reoperation is a challenge for heart surgeons because of the altered anatomy, adhesions, and scar tissue of the patients. Patients are also likely to be more apprehensive than they were the first time. Moreover, cardiologists face the difficult task of selecting patients who can benefit from a CABG reoperation vis-a-vis the risk factors for cardiac mortality, which can prevent long-term and cardiac event-free survival.
The objectives of our study were to determine the clinical outcome and the long-term prognosis of CABG reoperation in our center. Previous studies had addressed the issues of perioperative morbidity and mortality, cumulative survival, and cumulative cardiac event-free survival by studying series of 106 to 1,500 patients who underwent CABG reoperations.4 7 9 10 15 16 17 19 21 22 23 24 The mortality rates in these series varied from 2.8 to 9.2%, a perioperative MI was recorded in 0.8 to 8.9% of the patients, and the stroke incidence ranged from 0.9 to 3.5%. Similar figures were obtained in our series of 498 patients. The 5-year survival rates in other studies reached 81 to 93%, and the 10-year survival rates reached 65 to 75%. Our results for cumulative survival rates were 90.1%, 74%, and 63.4% at the 5-year, 10-year, and 15-year follow-ups, respectively. Our results for cardiac mortality alone were 91.4%, 80.3%, and 72.9% at the 5-year, 10-year, and 15-year follow-ups, respectively. In other studies, the cardiac event-free survival rates ranged from 28 to 86% at 5 years and then ranged from 30 to 48% at 10 years. In our patients, the cardiac event-free survival rates were 91.5%, 83.4%, and 67.8% at the 5-year, 10-year, and 15-year follow-ups, respectively.
We found that age, hypertension, and low LVEF adversely affected
the long-term survival of patients who have undergone CABG reoperation.
This was expected because it has already been recognized that these
factors decrease the chances of long-term survival for patients with a
variety of types of acquired heart disease who undergo either medical
or surgical treatment.2
Christenson et
al5
found that early CABG reoperation (ie,
1 year from primary bypass and usually due to graft failure) was
associated with an increased operative risk. The patient's age at the
time of the reoperation was a potent factor affecting perioperative
mortality17
19
and long-term survival.2
17
While Foster et al25
reported a 3% incidence of CABG
reoperations in 9,364 patients, the cumulative percentage of these
reoperations reached 11.4% at 10 years and an astounding 17.3% at 12
years. Christenson et al23
evaluated whether patients with
very low LVEF (ie,
25%) should be accepted for CABG
reoperation and concluded that such patients, as well as patients with
two- to three-vessel coronary artery diseases, should not categorically
be refused the CABG reoperation. Noppeney et al8
and Lytle
et al19
did not find any predominant risk factor that
influences long-term survival. LVEF, as determined by preoperative
angiography, proved to be a strong determinant of long-term survival in
other studies.2
17
19
26
Awad et al3
evaluated the outcome of cardiac reoperation in patients aged > 70
years and found that CABG reoperation carried an acceptable operative
morbidity and mortality with good functional improvement at medium-term
follow-up. Kron et al27
evaluated the results of CABG
reoperation in cases of chronic ischemic cardiomyopathy and found that
surgery in these patients is associated with substantially higher rates
of early mortality and morbidity. PTCA carries lower procedural
morbidity and mortality risks, although it is associated with less
complete revascularization and a greater need for subsequent
revascularization. Stephan et al24
addressed the issue of
the relative risks and benefits of PTCA and CABG reoperation in 632
patients. In their nonrandomized series of patients requiring
revascularization, an initial strategy of either PTCA or CABG
reoperation resulted in an equivalent overall survival, cardiac
event-free survival, and relief of angina. Although arterial grafts are
now used almost exclusively in our institution, they were rarely used
during the period covered by this study.
Improved outcomes of patients undergoing CABG reoperations depend on surgeons recognizing high risk conditions, acquiring more experience in the technical aspects of the surgery, bettering their selection of patients, and improving perioperative and postoperative care. Our study shows that the perioperative mortality and complication rates for CABG reoperation are relatively low. Long-term results regarding cumulative survival and cardiac event-free survival are also good. Although CABG reoperation is safe overall, advanced age, hypertension, and decreased LVEF function significantly increase the surgical risk.
| Acknowledgements |
|---|
| Footnotes |
|---|
Abbreviations: CABG = coronary artery bypass grafting; LVEF = left ventricular ejection fraction; MI = myocardial infarction; PTCA = percutaneous transluminal coronary angioplasty
Received for publication May 19, 1998. Accepted for publication January 4, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. F. Sabik III, E. H. Blackstone, P. L. Houghtaling, P. A. Walts, and B. W. Lytle Is Reoperation Still a Risk Factor in Coronary Artery Bypass Surgery? Ann. Thorac. Surg., November 1, 2005; 80(5): 1719 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Mauro, A. L. Iaco, M. Contini, G. Teodori, G. Vitolla, M. Pano, G. Di Giammarco, and A. M. Calafiore Reoperative Coronary Artery Bypass Grafting: Analysis of Early and Late Outcomes Ann. Thorac. Surg., January 1, 2005; 79(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Noyez and F. M. van Eck Long-term cardiac survival after reoperative coronary artery bypass grafting Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Canver and J. Chanda Intraoperative and postoperative risk factors for respiratory failure after coronary bypass Ann. Thorac. Surg., March 1, 2003; 75(3): 853 - 857. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |